Precision Biosciences Stock In The News

DTIL Stock  USD 4.61  0.03  0.65%   
Our overall analysis of Precision BioSciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Precision BioSciences. The specific impact of Precision BioSciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Precision BioSciences' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Precision BioSciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Precision BioSciences Backtesting and Precision BioSciences Hype Analysis.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Precision BioSciences Today Top News and Investor Outlook

Investing News at Macroaxis
Precision BioSciences reports promising DMD gene editing results
https://www.investing.com/news/company-news/precision-biosciences-reports-promising-dmd-gene-editing-results-93CH-4137467
 Bullish
Investing News at Macroaxis
Precision Biosciences director Brown buys $6963 in DTIL stock
https://www.investing.com/news/insider-trading-news/precision-biosciences-director-brown-buys-6963-in-dtil-stock-93CH-4114200
 Bullish
seekingalpha News
Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10%
https://seekingalpha.com/news/4462194-precision-biosciences-gets-fda-rare-disease-status-for-dmd-treatment-stock-jumps-10?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
Yahoo News
Sidoti Events, LLC's Virtual May Micro-Cap Conference
https://finance.yahoo.com/news/sidoti-events-llcs-virtual-may-120000903.html
 Bullish
Yahoo News
7 Biotech Stocks to Buy for Their Game-Changing Potential
https://finance.yahoo.com/news/7-biotech-stocks-buy-game-100000015.html
 Neutral
Yahoo News
TG Therapeutics Announces Global License...
https://finance.yahoo.com/news/tg-therapeutics-announces-global-license-120000448.html
 Neutral
Yahoo News
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
https://finance.yahoo.com/news/precision-biosciences-completes-license-deal-120000510.html
 Bullish
Yahoo News
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
https://finance.yahoo.com/news/precision-biosciences-announces-approval-first-132000457.html
 Bullish
Yahoo News
Precision BioSciences Announces Publicat...
https://finance.yahoo.com/news/precision-biosciences-announces-publication-nature-120000333.html
 Bullish
Yahoo News
Precision BioSciences to Present at Hep-DART 2023
https://finance.yahoo.com/news/precision-biosciences-present-hep-dart-120000901.html
 Bullish

Precision BioSciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Precision and other traded companies coverage with news coverage. We help investors stay connected with Precision headlines for the 20th of July to make an informed investment decision based on correlating the impacts of news items on Precision Stock performance. Please note that trading solely based on the Precision BioSciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Precision BioSciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Precision BioSciences investors visualize upcoming and past events in order to time the market based on Precision BioSciences noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Precision BioSciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Precision BioSciences' short interest history, or implied volatility extrapolated from Precision BioSciences options trading.
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Precision BioSciences Backtesting and Precision BioSciences Hype Analysis.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.87)
Revenue Per Share
6.481
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.18)
Return On Equity
(0.51)
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.